A phase II study of EDP-305 in patients with primary biliary cholangitis (PBC)

Trial Profile

A phase II study of EDP-305 in patients with primary biliary cholangitis (PBC)

Planning
Phase of Trial: Phase II

Latest Information Update: 19 Apr 2017

At a glance

  • Drugs EDP 305 (Primary)
  • Indications Primary biliary cirrhosis
  • Focus Therapeutic Use
  • Most Recent Events

    • 19 Apr 2017 According to an Enanta Pharmaceuticals media release, the company plans to initiate this study in the fourth quarter of 2017.
    • 12 Jan 2017 New trial record
    • 06 Jan 2017 According to an Enanta Pharmaceuticals media release, the company plans to initiate this study in the second half of 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top